At EMD Serono, we currently dedicate more that two-thirds of our R&D investment to oncology and immuno-oncology. Through biomarker-driven research, we aim to develop personalized treatments that address hard-to-treat cancers.
We are building a strong pipeline in oncology for an immuno-oncology program that includes potential new medicines in more than 15 difficult-to-treat tumour types with high unmet patient needs.
Ultimately, we aspire to discover and develop diverse treatment options and new approaches to cancer care. Together, we are building a strong position in this emerging area to help those with cancer, live longer, healthier lives.
When great minds get together, they inspire each other. Our collaborative culture proves it. By working a better way—sharing ideas, voicing opinions, giving feedback and lending support—we get better results.View All Jobs